8.10
Chronopharmacokinetics: Time-Dependent Pharmacokinetics
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes…
Chronopharmacokinetics studies the temporal change in drug absorption and elimination, whether cyclical or noncyclical.
Cyclic changes occur over constant intervals, while noncyclic changes extend over time.
Time-dependent pharmacokinetics refers to noncyclical changes in drug rate processes, leading to nonlinear pharmacokinetics.
It may result from changes in biochemistry or alteration in the physiology of organs, possibly impacting drug disposition.
Additionally, it can be due to the autoinduction or autoinhibition of biotransformation enzymes.
Autoinduction occurs when repeated drug doses induce the enzymes responsible for its elimination, increasing drug clearance.
Autoinhibition occurs when metabolites increase in concentration and inhibit the metabolism of the parent drug.
Drugs with time-dependent pharmacokinetics have variable clearance and elimination half-lives.
At certain periods of the day, some anticancer drugs are better tolerated. For instance, the antimetabolite drug fluorouracil, administered in rodents during the morning, was found to be the least toxic.
View the full transcript and gain access to JoVE Core videos
Q1: What is the difference between cyclical and noncyclical changes in chronopharmacokinetics?
Chronopharmacokinetics studies temporal changes in drug absorption and elimination. Cyclical changes occur over constant, regular intervals, while noncyclical changes extend over longer, irregular periods. Time-dependent pharmacokinetics refers specifically to noncyclical changes in drug rate processes, leading to nonlinear pharmacokinetics where drug concentration and time relationships are not proportional.
Q2: How does autoinduction affect drug clearance and elimination?
Autoinduction occurs when repeated drug doses induce the enzymes responsible for drug elimination, increasing drug clearance over time. This results in variable elimination half-lives and clearance rates. Conversely, autoinhibition happens when metabolites accumulate and inhibit parent drug metabolism, decreasing clearance. Both mechanisms exemplify how time-dependent pharmacokinetics creates nonlinear drug behavior.
Q3: What physiological factors can cause time-dependent pharmacokinetics?
Time-dependent pharmacokinetics can result from alterations in organ physiology or biochemistry, such as changes in enzyme activity or blood flow to specific organs affecting drug metabolism and clearance. These changes may also stem from autoinduction or autoinhibition of biotransformation enzymes. Such variations make drug disposition unpredictable and dependent on the timing and frequency of administration.
Q4: Why do drugs with time-dependent pharmacokinetics have variable elimination half-lives?
Drugs undergoing time-dependent pharmacokinetics exhibit variable clearance because their elimination rate changes over time due to enzyme induction, enzyme inhibition, or physiological alterations. This variability means elimination half-life depends on dose and administration timing rather than remaining constant. Understanding nonlinear pharmacokinetics dependence of elimination half-life and dose clearance is essential for optimizing therapeutic regimens.
Q5: How does the timing of drug administration affect toxicity in anticancer therapy?
Chronopharmacokinetics demonstrates that certain anticancer drugs are better tolerated at specific times of day. For example, the antimetabolite drug fluorouracil administered to rodents during the morning showed the least toxicity compared to other administration times. This circadian variation in drug response highlights the importance of considering temporal factors when scheduling chemotherapy to minimize adverse effects.
Q6: What is the relationship between time-dependent pharmacokinetics and nonlinear pharmacokinetics?
Time-dependent pharmacokinetics refers to noncyclical changes in drug rate processes over time, which leads to nonlinear pharmacokinetics. In nonlinear systems, the relationship between drug concentration and time is not proportional, meaning drug behavior cannot be predicted using simple linear models. This occurs because clearance and elimination rates change with repeated dosing or over extended periods.
Q7: Why is understanding chronopharmacokinetics important for drug therapy optimization?
Understanding chronopharmacokinetics and time-dependent pharmacokinetics is essential for tailoring drug regimens to individual patients and maximizing efficacy and safety. Variable clearance and elimination half-lives require consideration of administration timing to optimize therapeutic outcomes and minimize side effects. This knowledge enables clinicians to adjust dosing schedules based on temporal variations in drug absorption and elimination.